Soft Tissue Infections Clinical Trial
Official title:
A Placebo Controlled, Randomized, and Blinded Study of Antibiotic Treatment of Patients With Uncomplicated Soft Tissue Infection
This study is to determine whether antibiotic therapy is needed for patients with non-life threatening soft tissue infections. Most patients with these soft tissue infections are presently treated with antibiotics. Many of these infections resolve without proper antibiotic treatment. Treatment of patients with antibiotics after surgical drainage of an abscess may not be necessary and indiscriminate use of antibiotics may lead to colonization by drug-resistant organisms. Subsequent infection by drug resistant organisms may limit the choice of antibiotics in more complicated infections. A comparison between antibiotic treatment and no antibiotic treatment in surgically treated, uncomplicated soft tissue infections is needed to address this very important question.
The Integrated Soft Tissue Infection Service (ISIS) Clinic at San Francisco General Hospital
treats a large number of patients with soft tissue infections, and our data suggest that
antibiotics may be overused for these infections. Most of these infections are treated by
surgical drainage of an abscess (77%). When microbiologic cultures were performed, 88% of
the abscesses were infected with Staphylococcus aureus (S. aureus), and 55% of the abscesses
contained methicillin-resistant Staphylococcus aureus (MRSA). Recently, the high prevalence
of MRSA infection has been documented in San Francisco and throughout the country.
Presently, most patients are treated with antibiotics after drainage of the abscess. Our
retrospective analysis found that 60% of these infections resolved without appropriate
antibiotic treatment. These were patients infected with MRSA who were treated with an
antibiotic that was not active against that organism. This implies that surgical drainage of
these abscesses was probably the important treatment and antibiotic treatment was probably
not necessary.
Unnecessary use of antibiotics has adverse consequences. Some patients have allergic
reactions to antibiotics. Patients can develop serious gastrointestinal infections from
antibiotic use. Antibiotics are costly. But most importantly, overuse of antibiotics may be
the significant factor in the spread of antibiotic resistant organisms. The increased
prevalence of MRSA has made it extremely difficult to treat patients with appropriate
antibiotics in life threatening infections (i.e. bacterial endocarditis, osteomyelitis, and
necrotizing soft tissue infections).
The experience in the ISIS Clinic has brought into question our present practice of
antibiotic use in patients with surgically managed abscesses. Many surgeons practicing in
the ISIS clinic believe that antibiotics have little or no effect on the clinical course of
these uncomplicated infections. Elimination of antibiotic use for these uncomplicated
infections would certainly simplify care for these patients. It is even possible that
decreased antibiotic use may decrease the prevalence of MRSA colonization in this
population. However, decreased prevalence of MRSA colonization will not be specifically
addressed in this limited study. A randomized, prospective and blinded trial comparing
standard antibiotic treatment with no treatment should help determine whether antibiotics
are really needed for these infections.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04332679 -
Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes
|
N/A | |
Completed |
NCT02097615 -
Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water
|
Phase 4 | |
Completed |
NCT01557426 -
Soft Tissue Ultrasound of Infections
|
Phase 1 | |
Active, not recruiting |
NCT04257097 -
Reinforced PTFE Meshes Versus Customized Titanium Meshes
|
N/A | |
Enrolling by invitation |
NCT05826873 -
Discharge Stewardship in Children's Hospitals
|
N/A | |
Completed |
NCT04393909 -
Improving Safety of Diagnosis and Therapy in the Inpatient Setting
|
N/A | |
Active, not recruiting |
NCT02595047 -
Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint)
|
N/A | |
Completed |
NCT01790698 -
Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).
|
||
Completed |
NCT00785200 -
MRSA Colonization and Control in the Dallas County Jail
|
N/A | |
Completed |
NCT00426933 -
Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections
|
Phase 2 | |
Terminated |
NCT00102947 -
Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
|
Phase 4 | |
Completed |
NCT00451386 -
Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)
|
Phase 2 | |
Completed |
NCT03643952 -
Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
|
Phase 2 | |
Recruiting |
NCT02979951 -
Fosfomycin i.v. for Treatment of Severely Infected Patients
|
||
Completed |
NCT02600871 -
Skin and Soft Tissue Infection (SSTI) Study
|
Phase 4 | |
Completed |
NCT00303589 -
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections
|
Phase 2 | |
Completed |
NCT04286334 -
Three-dimensional Bone Regeneration Using Custom-made Meshes With and Without Collagen Membrane
|
N/A | |
Recruiting |
NCT05471908 -
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
|
N/A | |
Withdrawn |
NCT03982030 -
Dalbavancin Outpatient Pilot
|
Phase 4 | |
Terminated |
NCT00430937 -
Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections
|
Phase 3 |